Greater R&D Funding Needed to Fight Diseases Affecting World’s Poor

Despite significant advancements in increasing distribution and development of vaccines against childhood killer diseases – including pneumococcal disease, rotavirus, and Haemophilus influenzae Type B – global efforts to reduce the burden of infection from neglected tropical diseases (NTDs) has greatly lagged, argues Sabin Vaccine Institute (Sabin) President Dr. Peter Hotez in an article for the June edition of Health Affairs.

WHO report says pneumococcal immunization plays role in reducing childhood deaths

The Pneumococcal Council of Experts (PACE), an initiative of the Sabin Vaccine Institute, has led efforts to raise awareness of the burden of pneumococcal disease, the most common vaccine-preventable cause of death and a leading infectious killer of children worldwide.

Sabin

Revisarán propagación enfermedades neumocóccica

September 22, 2008 | Listin Diario

SANTO DOMINGO.- Científicos, autoridades y diseñadores de políticas de salud pública, representantes de agencias internacionales, directivos y miembros de sociedades especializadas de pediatría, infectologia y neumología del Caribe, revisarán en el pa ís los alcances de la propagación y control de la enfermedad neumocóccica, que mata al menos 114 niños cada hora en el mundo.

Health Experts Call on Global Leaders to Ensure Access to Life-Saving Pneumococcal Vaccines

Reykjavik, Iceland – Nearly 1,000 of the world’s leading experts on infectious diseases and vaccines are meeting during the 6th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-6) this week to call for renewed and urgent action by governments to protect their citizens against pneumococcal disease, a leading killer of children and adults worldwide.

Sabin

Pneumococcus Must be Included in the Conjugate Vaccination Scheme

Prof. Dr. Ciro A. de Quadros, co-chairman of the Pneumococcal Awareness Council of Experts (PACE), stated that there are seven children dying from diseases caused by pneumococcus bacteria every minute, pointing out that the pneumococcal conjugate vaccination was effective and safe in preventing such diseases.

Media Magazine

Asking for increased awareness of pneumococcal infections, experts warn: ‘Pneumococcal vaccine should be covered by social health insurance’

ISTANBUL — Having convened in the 3rd Regional Pneumococcal Symposium held in Istanbul, experts lamented the low pneumococcal awareness level and called for the pneumococcal vaccine to be covered by social health insurance. Speaking at the press conference, Prof. Dr. Mehmet Ceyhan, Chairman of Turkish Association of Infectious Diseases, said that “Treatment of disease is not enough alone.

Sabin

Pages